Snowflake

$SNOW declined 23% despite 30% revenue growth and surging $9.77B in obligations. Elevated valuation and continued losses temper buying enthusiasm.

Robbins Geller launches class action lawsuit against $SNOW, alleging securities fraud over false product efficiency claims and material business disclosures between June 2023 and February 2024.

Three companies face class action lawsuits alleging securities fraud. Boston Scientific stock fell 17% after missing earnings guidance amid alleged false revenue projections.

Snowflake Inc. faces securities class action lawsuit alleging false statements about product efficiency and features. Lead plaintiff deadline set for April 27, 2026.

PayPal faces class action lawsuit following Q4 2025 earnings miss, CEO departure, and withdrawn 2027 guidance amid operational challenges.

Snowflake faces class action alleging company concealed material information about product changes harming revenue while making misleading positive statements through early 2024.

Class action lawsuit filed against $SNOW alleges securities fraud over material nondisclosure of product changes and CEO transition, spanning June 2023-February 2024.

Snowflake stock fell 20% in 2026 despite bullish analyst ratings. Critics argue valuation remains elevated despite slowing growth and rising losses.

Snowflake delivered 30% revenue growth and solid customer metrics, but a 20% year-to-date decline and 10x forward P/S multiple present mixed signals for investors.

Snowflake shows recovery signals with 30% revenue growth, steady 125% net retention, and renewed institutional buying. AI partnerships and analyst optimism suggest potential 50% upside.

Class action lawsuit filed against Snowflake for allegedly making misleading statements about business impact while concealing product efficiency changes and pricing adjustments between June 2023 and February 2024.